(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -4.91%-423.35M | 31.11%-120.68M | -16.50%-403.53M | -92.85%-175.17M | -136.08%-346.36M | -209.12%-90.83M | -63.63%-146.71M | -1.20%-29.38M | -225.25%-89.66M | -139.97%-29.04M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 60.01%-6.1M | ---- | 39.43%-15.25M | ---- | 0.29%-25.18M | ---- | 51.69%-25.25M | ---- | 17.33%-52.27M | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | 83.03%-1.16M | 88.02%-1.16M | 29.35%-6.84M | -152.23%-9.69M | -935.72%-9.68M | ---3.84M | ---935K | ---- |
Impairment and provisions: | ---- | -1.63%10.88M | ---- | 101.18%11.06M | --7.02M | --5.5M | ---- | ---- | 51.44%15.39M | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --70K | ---- |
-Impairment of goodwill | ---- | ---- | ---- | --5.87M | --7.02M | ---- | ---- | ---- | 50.75%15.32M | ---- |
-Other impairments and provisions | ---- | 109.78%10.88M | ---- | -5.66%5.18M | ---- | --5.5M | ---- | ---- | ---- | ---- |
Revaluation surplus: | 105.55%266.14M | 243.14%82.38M | 33.97%129.48M | 170.11%24.01M | 276.53%96.65M | -6.88%-34.24M | 64.44%-54.75M | 36.76%-32.04M | 31.69%-153.97M | 67.30%-50.66M |
-Fair value of investment properties (increase) | 117.21%266.14M | 243.14%82.38M | 28.10%122.53M | 170.11%24.01M | 286.01%95.65M | -6.88%-34.24M | 64.92%-51.42M | 36.76%-32.04M | 34.72%-146.59M | 67.30%-50.66M |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | 13.42%-4.06M | ---- | ---4.69M | ---- |
-Other fair value changes | ---- | ---- | 595.60%6.95M | ---- | 35.92%999K | ---- | 127.33%735K | ---- | -215.24%-2.69M | ---- |
Asset sale loss (gain): | -100.00%2K | -100.84%-783K | 212,679.55%93.54M | --92.75M | 99.72%-44K | ---- | -269.74%-15.91M | ---- | 3,533.70%9.37M | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | --93.53M | --92.75M | ---- | ---- | -269.36%-15.87M | ---- | --9.37M | ---- |
-Loss (gain) on sale of property, machinery and equipment | -66.67%2K | ---783K | 113.64%6K | ---- | -4.76%-44K | ---- | -1,150.00%-42K | ---- | 101.47%4K | ---- |
Depreciation and amortization: | -11.07%14.73M | ---- | -30.36%16.56M | ---- | 38.77%23.78M | ---- | 41.64%17.14M | ---- | 171.73%12.1M | ---- |
Financial expense | -6.78%173.5M | -21.94%88.49M | -35.50%186.12M | -18.85%113.36M | 15.44%288.56M | 13.26%139.7M | 5.53%249.97M | 9.18%123.35M | 18.75%236.87M | 13.83%112.98M |
Special items | 12.98%46.51M | ---- | 707.41%41.17M | ---- | 352.44%5.1M | ---- | -80.49%1.13M | ---- | -65.31%5.78M | ---2.59M |
Operating profit before the change of operating capital | 52.25%71.43M | -7.04%60.28M | 9.94%46.92M | 521.41%64.84M | 167.94%42.68M | -82.04%10.44M | 191.89%15.93M | 89.24%58.09M | -229.23%-17.33M | 80.82%30.7M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 199.46%12.92M | ---- |
Developing property (increase)decrease | 9.44%-77.25M | ---- | 51.75%-85.3M | ---- | ---176.79M | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | -15.66%8.3M | 81.95%-556K | 292.13%9.84M | 53.97%-3.08M | 77.38%-5.12M | -200.22%-6.69M | -402.22%-22.64M | 115.27%6.68M | 113.05%7.49M | -227.48%-43.72M |
Accounts payable increase (decrease) | -35.26%29.51M | ---- | -45.32%45.59M | -85.14%177K | 1,441.03%83.39M | 189.08%1.19M | -73.52%5.41M | 102.78%412K | 130.30%20.43M | 73.77%-14.81M |
Advance payment increase (decrease) | 137.20%1.63M | ---- | -2.31%-4.39M | ---- | -2,133.33%-4.29M | ---- | -109.58%-192K | ---- | -74.38%2.01M | ---- |
Special items for working capital changes | -104.46%-1.8M | ---- | -62.19%40.25M | ---- | 217.82%106.45M | ---- | -2,647.07%-90.35M | ---- | 95.19%-3.29M | ---- |
Cash from business operations | 300.98%190.34M | -3.58%59.72M | 2.49%47.47M | 1,155.39%61.94M | 150.43%46.32M | -92.43%4.93M | -513.17%-91.84M | 334.22%65.18M | 112.02%22.23M | -438.26%-27.83M |
Hong Kong profits tax paid | ---- | ---- | 75.14%-90K | ---- | -34.07%-362K | ---- | 94.82%-270K | ---- | -37,107.14%-5.21M | ---- |
China income tax paid | 30.81%-1.3M | ---- | 66.87%-1.88M | ---- | -88.29%-5.66M | ---- | -290.52%-3.01M | ---- | 83.24%-770K | ---- |
Interest received - operating | -35.27%2.66M | ---- | -67.66%4.11M | ---- | 0.35%12.7M | ---- | -73.73%12.65M | ---- | -9.79%48.16M | ---- |
Special items of business | ---- | 226.93%138.49M | ---- | -58.50%42.36M | ---- | 155.56%102.06M | ---- | -623.94%-183.68M | ---- | 158.15%35.06M |
Net cash from operations | 286.43%191.7M | 90.03%198.21M | -6.38%49.61M | -2.52%104.3M | 164.25%52.99M | 190.29%106.99M | -228.03%-82.47M | -1,739.22%-118.5M | 147.31%64.41M | 111.04%7.23M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -80.45%760K | -81.93%383K | -12.10%3.89M | -1.58%2.12M | -7.02%4.42M | -15.47%2.15M | 1.08%4.76M | 3,701.49%2.55M | -50.40%4.71M | -96.92%67K |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | --3.65M | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | -82.75%19.49M | -91.00%7.32M | 1,601.79%113.03M | 3,318.72%81.34M | -84.31%6.64M | -106.83%-2.53M | -79.22%42.34M | -82.37%37.01M | 1,509.52%203.72M | 417.59%209.97M |
Sale of fixed assets | ---- | --1.52M | -88.01%124K | ---- | 1,176.54%1.03M | -63.38%26K | 131.43%81K | 787.50%71K | -87.32%35K | -46.67%8K |
Purchase of fixed assets | 94.61%-1.28M | -81.18%-308K | -157.10%-23.82M | 92.96%-170K | 51.05%-9.27M | 85.47%-2.42M | 53.50%-18.93M | -2,991.45%-16.63M | -370.99%-40.71M | -19.29%-538K |
Purchase of intangible assets | ---- | ---- | ---- | 90.09%-10.14M | ---53K | ---102.31M | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | --158.71M | --152.75M | ---- | ---- | -81.57%18.76M | --19M | --101.81M | ---- |
Recovery of cash from investments | ---- | ---- | -13.47%11.45M | --6.93M | 515.91%13.24M | ---- | -42.01%2.15M | ---- | --3.71M | --3.99M |
Cash on investment | ---- | ---- | ---- | ---- | -80.34%-38.66M | ---24K | 76.38%-21.44M | ---- | -620.26%-90.74M | 82.10%-16.42M |
Net cash from investment operations | -92.80%18.97M | -96.17%8.92M | 1,263.42%263.39M | 329.49%232.81M | -181.66%-22.64M | -341.56%-101.45M | -84.81%27.72M | -78.69%42M | 252.15%182.53M | 498.57%197.07M |
Net cash before financing | -32.69%210.67M | -38.56%207.13M | 931.32%313M | 5,979.59%337.11M | 155.44%30.35M | 107.25%5.55M | -122.17%-54.74M | -137.45%-76.5M | 196.41%246.94M | 277.81%204.3M |
Cash flow from financing activities | ||||||||||
New borrowing | -90.15%128.56M | -75.73%62.53M | 117.03%1.31B | -6.33%257.68M | -19.37%601.57M | 11.83%275.09M | -82.55%746.06M | -69.41%245.98M | 42.51%4.27B | -47.68%804.16M |
Refund | 84.45%-207.98M | 65.56%-164.92M | -318.14%-1.34B | -409.45%-478.87M | 58.58%-319.85M | -93.58%-94M | 82.94%-772.14M | 95.10%-48.56M | -60.54%-4.53B | 35.01%-991.74M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | --333.25M | ---- | ---- | ---- |
Issuance of bonds | ---- | ---- | ---- | ---- | -10.83%59.3M | -10.83%59.3M | -78.64%66.5M | -79.06%66.5M | --311.28M | --317.53M |
Interest paid - financing | 27.38%-129.02M | 29.73%-82.19M | 3.54%-177.67M | -70.45%-116.96M | 8.15%-184.18M | 36.39%-68.62M | -91.12%-200.53M | -9.07%-107.88M | 22.51%-104.92M | -24.84%-98.91M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 20,182.00%10.14M | 20,182.00%10.14M |
Issuance expenses and redemption of securities expenses | -124.43%-74.53M | -281.78%-81.83M | 79.94%-33.21M | 87.06%-21.43M | -56.52%-165.58M | -179.24%-165.58M | 62.42%-105.79M | 76.85%-59.3M | -8,482.32%-281.5M | -7,707.32%-256.08M |
Other items of the financing business | ---- | ---- | ---11.72M | ---- | ---- | ---- | ---97K | ---- | ---- | ---- |
Net cash from financing operations | -9.52%-287.66M | 26.17%-268.69M | -1,432.29%-262.65M | -18,792.09%-363.94M | -129.88%-17.14M | -97.86%1.95M | 117.72%57.36M | 141.83%90.86M | -315.17%-323.64M | -680.17%-217.19M |
Effect of rate | -113.53%-5.7M | -154.19%-3.27M | -305.94%-2.67M | 61.82%6.04M | 11.24%1.3M | 139.16%3.73M | -93.85%1.17M | -404.45%-9.52M | 547.63%18.95M | 85.95%-1.89M |
Net Cash | -252.90%-76.98M | -129.54%-61.57M | 281.19%50.35M | -458.01%-26.82M | 404.51%13.21M | -47.81%7.49M | 103.41%2.62M | 211.32%14.36M | 27.44%-76.7M | 83.35%-12.9M |
Begining period cash | 111.90%90.29M | 111.90%90.29M | 46.09%42.61M | 46.09%42.61M | 14.90%29.17M | 14.90%29.17M | -69.47%25.38M | -69.47%25.38M | -56.94%83.14M | -56.94%83.14M |
Cash at the end | -91.58%7.61M | 16.62%25.45M | 106.75%90.29M | -45.97%21.82M | 49.73%43.67M | 33.67%40.39M | 14.90%29.17M | -55.80%30.21M | -69.47%25.38M | -33.11%68.35M |
Cash balance analysis | ||||||||||
Cash and bank balance | -91.58%7.61M | ---- | 111.90%90.29M | ---- | 46.09%42.61M | ---- | --29.17M | ---- | ---- | ---- |
Cash and cash equivalent balance | -91.58%7.61M | ---- | 111.90%90.29M | ---- | 46.09%42.61M | ---- | --29.17M | ---- | ---- | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | -- | National Health Certified Public Accountants Limited | -- | National Health Certified Public Accountants Limited | -- | National Health Certified Public Accountants Limited | -- | National Health Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data